Clinical study of therapeutic effect of Xuebijing injection on the treatment of vascular endothelial cell injury, microcirculation disorder and organ diysfunction in patients with sepsis
2017
Objective
To observe the clinical therapeutic effect of Xuebijing injection on vascular endothelial cell (VEC) injury, microcirculation disorder and organ dysfunction in patients with sepsis.
Methods
Seventy-three patients with sepsis were randomly divided into two groups: Xuebijing injection-treated group (40 cases) and control group (33 cases). Routine medicine therapy was applied in both groups.Additionally, the Xuebijing injection-treated group was treated with Xuebijing injection 100 ml and saline 100 ml by intravenous drip every 12 hours for consecutive 5 days.Vascular endothelial injury index, including soluble thrombomodulin(sTM), vascular endothelial growth factor 2 (VEGF-2), endothelial specific molecule 1 (ESM-1), microcirculation index of arterial blood lactic acid (Lac), central venous oxygen saturation (ScvO2), total microvessel density (TVD), the perfusion vascular density (PVD), proportion of perfused vessels (PPV) and microvessel flow index (MFI) of the two groups before and after therapy were observed and the sequential organ failure score (SOFA) was recorded before and after treatment.
Results
Senventy-three patients with sepsis had different degrees of increase in vascular endothelial damage markers, lactate and sequential organ failure scores in arterial blood, while the central venous blood oxygen saturation (ScvO2), the total vascular density of the sublingual microvasculature (TVD), perfused vessel density (PVD), proportion of perfused vessels (PPV) and microcirculatory flow index (MFI) decreased before treatment.After 5-day treatment, the above indicators of all patients were improved, the indexes in the Xuebijing injection group decreased significantly, compared with the control group , sTM ( (16.91±4.55) μg/L, (19.51±4.09) μg/L, t=-6.021, P<0.05), VEGF-2 (50.8(17.8, 127.7) ng/L vs.74.9(22.7, 155.1) ng/L, t=4.227, P<0.05), ESM-1 ( (10.20±2.43) μg/L vs.(14.80±3.52) μg/L, t=-4.113, P<0.05), Lac( (2.1±0.7) mmol/L vs.(3.7±1.1) mmol/L, t=2.366, P<0.05) and SOFA ( (5.9±2.1) vs.(8.7±2.6), t=-7.990, P<0.05). ScvO2 ( (0.771±0.153) % vs.(0.641±0.113) %, t=5.061, P<0.05), PVD ( (16.8±6.1) mm/mm2 vs.(12.1±5.1) mm/mm2, t=4.002, P<0.05), PPV ( (66.2±21.3) % vs.(50.4±19.3) %, t=-2.550, P<0.05) and MFI (6.2±2.4) vs.(3.8±2.2), t=-5.001, P<0.05) were significantly higher than those in the control group in the same period.sTM and PPV had a significant negative correlation (r=-0.755, P=0.000), PVD, PPV, ESM-1 and MFI were negatively correlated (r=-0.665, P=0.000; r=-0.600, P=0.000; r=-0.469, P=0.000), PPV, MFI and SOFA were negatively correlated (r=-0.798, P=0.000; r=-0.995, P=0.000); sTM, ESM-1 and SOFA were significantly positively correlated (r=0.883, P=0.000; r=0.881, P=0.000).
Conclusion
Vascular endothelial cell dysfunction probably plays an important role in the pathophysiology of sepsis and Xuebijing injection has therapeutic effect on sepsis by protecting vascular endothelial cell function.
Key words:
Sepsis; Xuebijing injection; Vascular endothelial cell; Microcirculation disorder
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI